RDX and tongue squamous cell carcinoma: For instance, miR-409-3p may delay the proliferation of tongue squamous cell carcinoma cells by inhibiting of radixin (RDX) to decrease its migratory and invasive abilities, which may be a potential target for the clinical treatment of tongue squamous cell carcinoma [30].